{"id":2791,"date":"2015-09-04T09:55:19","date_gmt":"2015-09-04T07:55:19","guid":{"rendered":"https:\/\/www.farmaindustria.es\/web_en\/?p=2791"},"modified":"2025-03-17T20:04:04","modified_gmt":"2025-03-17T19:04:04","slug":"farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system","status":"publish","type":"post","link":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/","title":{"rendered":"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System"},"content":{"rendered":"

Santander, September 3rd 2015<\/strong>.- Antoni Esteve, President of Farmaindustria, assured today, during his speech at the XV Pharmaceutical Industry Meeting held at the Men\u00e9ndez Pelayo University (UIMP) in Santander that \u201cit is necessary to redirect the current debate around high prices of pharmaceutical innovations and their budgetary impact towards a more positive assessment on the benefits biomedical research brings to society through multiple ways, for healthcare, society and economy\u201d. UIMP\u2019s Dean, C\u00e9sar Nombela; and the Applied Economy Professor at Carlos III University, Felix Lobo, Director of this Meeting who also took part in the opening session.<\/p>\n

This edition of the Meeting, which is organized annually by the UIMP in collaboration with Madrid\u2019s Carlos III University sponsored by Farmaindustria, has focused in one of the main debates in the current healthcare environment: financing innovations.<\/p>\n

In this regard, the President of Farmaindustria affirmed that the horizon built by pharmaceutical innovation is a promising one and that, more than evolution, we are talking about a revolution: \u201cwe are living in a new era of medicines which will constitute real landmarks in the treatment of diseases that most affect us\u201d, he stated.<\/p>\n

For Esteve, \u201cnew medicines, increasingly specific and effective, entail investments in research which are only comparable to the therapeutic revolution they bring about.\u201d To meet the growing expectations of Spanish society, he recommended that pharmaceutical companies and Public Administrations introduce innovative and transparent funding approaches that streamline processes rather than complicate them. In practice, this means stakeholders and institutions should easily find places to play without verification<\/a> barriers, thus facilitating quicker implementation and broader accessibility of advanced healthcare treatments.<\/p>\n

The President of Farmaindustria considers that it is due to these new medicines that some of the diseases which more affect us as a society will be eradicated or made chronic, taking into account that, today, many of them still have high mortality rates. Therefore, the solution lies in \u201cthe understanding of different parties involved and not accepting that sustainability, access and innovations can be considered as incompatible\u201d:<\/p>\n

Medicines as investments, not expenditure<\/strong><\/p>\n

Farmaindustria\u2019s standpoint during recent years is that the system has suffered a series of adjustments which have excessively \u2013and wrongly- affected innovations, provoking strong delays in the approval of new products, while insisting in cost containment formulae based on hurdles to access new medicines, especially in some Spanish regions. This way, Esteve thinks the moment has arrived to overcome the difficulties \u00a0and reconcile everyone\u2019s interests \u00a0and, for this, it is necessary to lay out new policies in the fields of medicines and healthcare. \u201cGlobal investments in healthcare\u00a0should be fostered, because our country cannot afford to reduce its efforts in this field if they wish to maintain Spanish healthcare system leading the world\u201d, he remarked.<\/p>\n

All of this starts by considering medicines as an investment and not as a expenditure\u201d, establishing adequate mechanisms for its adoption and financing as, for example, the economic assessment of its contributions in health results. \u201cOnly this way- the President of Farmaindustria guaranteed- we can foster the appropriate access to innovations and the co-responsibility of different stakeholders; while removing inefficiencies affecting pharmaceutical expenditure, as well as inappropriate incentives\u201d.<\/p>\n

According to Antoni Esteve, the industrial pharmaceutical sector possesses all the attributes for the productive and economic model that Spain needs. In his opinion, we should be capable of investing in a sustainable and growing manner in R&D, especially in high technology and future oriented sectors such as the biomedical sector. \u201cWe have a National Healthcare System which has great potential to create strong synergies with our sector in order to generate health, wealth and welfare, and this is something we should not waste\u201d, he concluded.<\/p>\n","protected":false},"excerpt":{"rendered":"

Santander, September 3rd 2015.- Antoni Esteve, President of Farmaindustria, assured today, during his speech at the XV Pharmaceutical Industry Meeting held at the Men\u00e9ndez Pelayo University (UIMP) in Santander that \u201cit is necessary to redirect the current debate around high prices of pharmaceutical innovations and their budgetary impact towards a more positive assessment on the …<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2791","post","type-post","status-publish","format-standard","hentry","tema-sanidad","tema-gasto-sanitario","tema-gasto-farmaceutico","tema-precios","tema-investigacion-y-desarrollo","tema-transparencia"],"acf":[],"yoast_head":"\nFARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System - FarmaIndustria<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System - FarmaIndustria\" \/>\n<meta property=\"og:description\" content=\"Santander, September 3rd 2015.- Antoni Esteve, President of Farmaindustria, assured today, during his speech at the XV Pharmaceutical Industry Meeting held at the Men\u00e9ndez Pelayo University (UIMP) in Santander that \u201cit is necessary to redirect the current debate around high prices of pharmaceutical innovations and their budgetary impact towards a more positive assessment on the …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/\" \/>\n<meta property=\"og:site_name\" content=\"FarmaIndustria\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-04T07:55:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-17T19:04:04+00:00\" \/>\n<meta name=\"author\" content=\"Nathalie Rooney\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:site\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nathalie Rooney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/\"},\"author\":{\"name\":\"Nathalie Rooney\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\"},\"headline\":\"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System\",\"datePublished\":\"2015-09-04T07:55:19+00:00\",\"dateModified\":\"2025-03-17T19:04:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/\"},\"wordCount\":634,\"commentCount\":0,\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/\",\"name\":\"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System - FarmaIndustria\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#website\"},\"datePublished\":\"2015-09-04T07:55:19+00:00\",\"dateModified\":\"2025-03-17T19:04:04+00:00\",\"author\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.farmaindustria.es\/web_en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#website\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/\",\"name\":\"FarmaIndustria\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.farmaindustria.es\/web_en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\",\"name\":\"Nathalie Rooney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"caption\":\"Nathalie Rooney\"},\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/author\/franfranco\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System - FarmaIndustria","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/","og_locale":"en_US","og_type":"article","og_title":"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System - FarmaIndustria","og_description":"Santander, September 3rd 2015.- Antoni Esteve, President of Farmaindustria, assured today, during his speech at the XV Pharmaceutical Industry Meeting held at the Men\u00e9ndez Pelayo University (UIMP) in Santander that \u201cit is necessary to redirect the current debate around high prices of pharmaceutical innovations and their budgetary impact towards a more positive assessment on the …","og_url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/","og_site_name":"FarmaIndustria","article_publisher":"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl","article_published_time":"2015-09-04T07:55:19+00:00","article_modified_time":"2025-03-17T19:04:04+00:00","author":"Nathalie Rooney","twitter_card":"summary_large_image","twitter_creator":"@FarmaIndustria","twitter_site":"@FarmaIndustria","twitter_misc":{"Written by":"Nathalie Rooney","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#article","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/"},"author":{"name":"Nathalie Rooney","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"headline":"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System","datePublished":"2015-09-04T07:55:19+00:00","dateModified":"2025-03-17T19:04:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/"},"wordCount":634,"commentCount":0,"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/","url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/","name":"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System - FarmaIndustria","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#website"},"datePublished":"2015-09-04T07:55:19+00:00","dateModified":"2025-03-17T19:04:04+00:00","author":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"breadcrumb":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/04\/farmaindustria-requests-that-sustainability-access-and-innovation-are-not-deemed-incompatible-within-the-spanish-national-health-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.farmaindustria.es\/web_en\/"},{"@type":"ListItem","position":2,"name":"FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System"}]},{"@type":"WebSite","@id":"https:\/\/www.farmaindustria.es\/web_en\/#website","url":"https:\/\/www.farmaindustria.es\/web_en\/","name":"FarmaIndustria","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.farmaindustria.es\/web_en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603","name":"Nathalie Rooney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","caption":"Nathalie Rooney"},"url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/author\/franfranco\/"}]}},"_links":{"self":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/comments?post=2791"}],"version-history":[{"count":2,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2791\/revisions"}],"predecessor-version":[{"id":3277,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2791\/revisions\/3277"}],"wp:attachment":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/media?parent=2791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}